Skip to search formSkip to main contentSkip to account menu

Xenical

Known as: Hoffmann-La Roche brand of orlistat, Roche brand of orlistat 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Background: Orlistat (Xenical) is an approved medication for treating obesity. Recent studies suggested a new application for… 
2010
2010
Objective: To compare the pharmaceutical quality of Xenical (chemically produced orlistat) with nine generic products, each… 
2008
2008
Objective: The purpose of this study was to examine the possible effects of a gastrointestinal lipase inhibitor “Orlistat… 
Review
2000
Review
2000
The term “obesity” implies an excess of adipose tissue (fat) and excess adiposity is a health risk. In most cases it develops in… 
1999
1999
AbstractObjective: We detected markedly decreased cyclosporin blood levels in a heart-transplanted patient after the… 
Review
1999
Review
1999
Review
1999
The introduction of orlistat (Roche, UK) at the end of last year received considerable media coverage and was heralded in some…